Selventa Raises $5M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life science data analysis firm Selventa has raised $5 million in an equity round, it disclosed in a document filed with the US Securities and Exchange Commission this week.

The company did not say how the funds would be used and did not disclose participants in the financing, though it said nine people invested in the round.

A company official was not available for comment, a spokesperson said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.

Researchers report that what scents someone picks up can reflect their complement of immune genes.

The New York Times examines ethics and China's push to lead biomedical research.

At her blog, Sally Rockey dives into National Institutes of Health funding data.